News
AMPE
0.3751
-9.18%
-0.0379
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/24 17:32
Ampio Pharmaceuticals to implement 1-for-15 reverse stock split
Seekingalpha · 11/08 21:45
Ampio Pharmaceuticals Issues Letter to Stockholders
Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino.
PR Newswire · 10/14 20:01
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers
Benzinga · 10/04 17:53
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Benzinga · 10/04 16:41
Ampio Pharmaceuticals Issues Letter To Stockholders
Ampio Pharmaceuticals, Inc. (NYSE:AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino. Dear Fellow Ampio Stockholder, On
Benzinga · 10/04 12:56
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
Ampio Pharmaceuticals, Inc. (NYSE:AMPE) (the "Company") received written notification from NYSE American LLC ("NYSE American" or the "Exchange") stating that the staff of NYSE Regulation has
Benzinga · 10/04 12:50
Why T2 Biosystems Is Trading Higher By 18%; Here Are 28 Stocks Moving Premarket
Gainers HHG Capital Corporation (NASDAQ: HHGC) shares rose 42.1% to $14.56 in pre-market trading.
Benzinga · 09/23 11:16
Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket
Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday.
Benzinga · 09/21 10:16
Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket
Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.
Benzinga · 09/14 10:19
Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket
Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
Benzinga · 09/08 11:27
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Benzinga · 09/06 10:41
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Benzinga · 09/06 06:55
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session
Gainers
Benzinga · 09/02 16:18
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
Gainers
Benzinga · 09/02 10:26
Ampio Pharmaceuticals Extends Chief Executive Michael Martino's Employment; Shares Up
Ampio Pharmaceuticals Extends Chief Executive Michael Martino's Employment; Shares Up
MT Newswires · 09/02 10:16
--Alliance Global Downgrades Ampio Pharmaceuticals to Neutral From Buy
--Alliance Global Downgrades Ampio Pharmaceuticals to Neutral From Buy
MT Newswires · 08/08 05:45
Ampio announces 55% reduction of staff as key development program ends
Ampio Pharmaceuticals (NYSE:AMPE), a clinical-stage c...
Seekingalpha · 08/03 15:07
BRIEF-Ampio Pharmaceuticals - Committed To Reduction In Force That Will Result In The Termination Of 10 Of The Co's 18 Employees
BRIEF-Ampio Pharmaceuticals - Committed To Reduction In Force That Will Result In The Termination Of 10 Of The Co's 18 Employees
Reuters · 08/03 12:42
More
Webull provides a variety of real-time AMPE stock news. You can receive the latest news about Ampio Pharma through multiple platforms. This information may help you make smarter investment decisions.
About AMPE
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the research, development, and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. The Company's lead product candidate, Ampion has immunomodulatory action and anti-inflammatory effects, which provide a treatment for individuals with inflammatory conditions including, but not limited to, severe osteoarthritis of the knee (OAK); osteoarthritis related to other joints, such as hip, shoulder, ankle and hand; and the widespread inflammation associated with COVID-19 infection. Ampion is in development as an intra-articular injection treatment for severe OAK, an intravenous (IV) and inhaled treatment for hospitalized severe and/or critical COVID-19 patients, and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19, referred to as Long-COVID. Its clinical studies include AP-013, AP-017, AP-019 and AP-018.